Picard Medical Inc Revenue Growth Rates (PMI), Current and Historic Growth - CSIMarket
CSIMarket
 


Picard Medical Inc   (NYSEAMER: PMI)
 

PMI's Revenue Growth by Quarter and Year

Picard Medical Inc 's Revenue results by quarter and year




PMI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2.95
1st Quarter March 1.15
FY 4.10





PMI Revenue second quarter 2026 Y/Y Growth Comment
Picard Medical Inc reported Revenue improvement of 38.69% year on year in the second quarter 2026, to $ 2.95 millions, this is lower than Picard Medical Inc 's recent average Revenue rise of 47.22%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue growth. While Picard Medical Inc ' s Revenue rise of 38.69% ranks overall at the positon no. 590 in the second quarter 2026.




PMI Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - -64.18 % -99.98 % 17.57 %
3rd Quarter September - -1.14 % - -
2nd Quarter June 38.69 % 208.7 % - -
1st Quarter March 85.48 % - - -
FY   - 5.47 % -99.97 % -

Financial Statements
Picard Medical Inc 's second quarter 2026 Revenue $ 2.95 millions PMI's Income Statement
Picard Medical Inc 's second quarter 2025 Revenue $ 2.13 millions Quarterly PMI's Income Statement


PMI Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 16.09 % 220.45 % -
3rd Quarter September - -59.15 % 27.54 % -
2nd Quarter June 156.87 % 243.55 % - -
1st Quarter March 13.86 % -78.01 % - -
FY (Year on Year)   - 5.47 % -99.97 % -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #141
Overall #590

Revenue Y/Y Growth Statistics
High Average Low
207.06 % 47.22 % -64.17 %
(Mar 31 2026)   (Jun 30 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #141
Overall #590
Revenue Y/Y Growth Statistics
High Average Low
207.06 % 47.22 % -64.17 %
(Mar 31 2026)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Picard Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
243.71 % 53.38 % -100 %
(Jun 30 2025)  


PMI's II. Quarter Q/Q Revenue Comment
Picard Medical Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 156.87%, to $ 2.95 millions, from $1.15 millions in the first quarter.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Picard Medical Inc 's Revenue growth quarter on quarter, overall rank is 106.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #35
Overall #106
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #35
Overall #106
Revenue Q/Q Growth Statistics
High Average Low
243.71 % 53.38 % -100 %
(Jun 30 2025)  


PMI's II. Quarter Q/Q Revenue Comment
Picard Medical Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 156.87%, to $ 2.95 millions, from $1.15 millions in the first quarter.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Picard Medical Inc 's Revenue growth quarter on quarter, overall rank is 106.


Picard Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 5.98 $ 5.16 $ 4.63 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) -7.21 % 2.97 % - - -
Year on Year Revenue Growth Overall Ranking # 835 # 745 # 733 # 731 # 642
Seqeuential Revenue Change (TTM) 15.95 % 11.45 % -28.07 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 3162 # 745 # 733 # 731 # 642


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Picard Medical Inc reported a decrease in Revenue by -7.21% year on year, to $6 millions, compare to the 2.97% growth at Mar 31 2026.

In the Healthcare sector 175 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 745 to 835.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 176
Overall # 835

Revenue TTM Y/Y Growth Statistics
High Average Low
18.66 %
13.74 %
4.98 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 433
S&P 500 # 3162
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Picard Medical Inc reported a decrease in Revenue by -7.21% year on year, to $6 millions, compare to the 2.97% growth at Mar 31 2026.

In the Healthcare sector 175 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 745 to 835.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 176
Overall # 835

Revenue TTM Y/Y Growth Statistics
High Average Low
18.66 %
13.74 %
4.98 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 433
S&P 500 # 3162




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PMI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions


About Picard Medical Inc Revenue Growth Rates (PMI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Picard Medical Inc (CIK 2030617).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-028565
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Picard Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.